专利详细信息
专利号 | WO2004069167A3 |
专利标题 | Method and compositions for treating male infertility |
专利权人 | Nastech Pharmaceutical Company Inc.; |
发明人 | Quay, Steven C; |
申请号 | WO2004US02400 |
申请日 | 2004/1/27 |
公开日 | 2004/10/28 |
优先权号 | |
IPC | A61K03119500; |
专利类型 | |
法律状态查询 | 查看法律状态 |
The use of ejaculatory-enhancing agents to treat males having low sperm counts to promote fertilization of an ovum. The ejaculatory-enhancing agents are used to promote more frequent ejaculations thus producing more sperm thus increasing the chance for the ovum to be fertilized because more sperm are available. The fertilization of the ovum can be by sexual intercourse with a female or by in vitro or artificial insemination fertilization. Examples of ejaculatory enhancing agents are dopamine receptor agonists specific phosphodiesterase-5 (PDE-V) inhibitors organic nitrates L-arginine and combinations thereof. The dopamine receptor agonists include apomorphine a pharmaceutically acceptable addition salt of apomorphine a derivative of apomorphine bromocriptine ropinirole cabergoline pramipexole roxindole and lisuride. Examples of PDE-V inhibitors include sildenafil tadalafil and vardenafil. Examples of organic nitrates include glycerol trinitrate amyl nitrite isosorbide dinitrate isosorbide-5-mononitrate and erythrityl tetranitrate.
没有相关的数据
没有相关的数据
暂无附图
注:除CN专利外,本系统默认提供的所有其他中文标题和摘要来自机器翻译。